Literature DB >> 30205401

Levels of Proinflammatory Cytokines, Oxidative Stress, and Tissue Damage Markers in Patients with Acute Heart Failure with and without Cardiorenal Syndrome Type 1.

Grazia Maria Virzì1,2, Andrea Breglia1,2,3, Alessandra Brocca1,2,4, Massimo de Cal1,2, Chiara Bolin5, Giorgio Vescovo5,6, Claudio Ronco1,2.   

Abstract

BACKGROUND: Cardiorenal syndrome type 1 (CRS type 1) is characterized by a rapid worsening of cardiac function leading to acute kidney injury (AKI). Inflammation and oxidative stress seem to play a pivotal role in its pathophysiology. In this in vivo study, we examined the putative role of inflammation and humoral markers in the pathogenesis of the CRS type 1.
METHODS: We enrolled 53 patients with acute heart failure (AHF); 17 of them developed AKI (CRS type 1). The cause of AKI was presumed to be related to cardiac dysfunction after having excluded other causes. We assessed the plasma levels of proinflammatory cytokines (TNF-α, IL-6, IL-18, sICAM, RANTES, GMCSF), oxidative stress marker (myeloperoxidase, MPO), brain natriuretic peptide (BNP), and neutrophil gelatinase-associated lipocalin (NGAL) in AHF and CRS type 1 patients.
RESULTS: We observed a significant increase in IL-6, IL-18, and MPO levels in CRS type 1 group compared to AHF (p < 0.001). We found higher NGAL at admission in the CRS type 1 group compared to the AHF group (p = 0.008) and a positive correlation between NGAL and IL-6 (Spearman's rho = 0.45, p = 0.003) and between IL-6 and BNP (Spearman's rho = 0.43, p = 0.004). We observed lower hemoglobin levels in CRS type 1 patients compared to AHF patients (p < 0.05) and inverse correlation between hemoglobin and cytokines (IL-6: Spearman's rho = -0.38, p = 0.005; IL-18: Spearman's rho = -0.32, p = 0.02).
CONCLUSION: Patients affected by CRS type 1 present increased levels of proinflammatory cytokines and oxidative stress markers, increased levels of tissue damage markers, and lower hemoglobin levels. All these factors may be implicated in the pathophysiology of CRS type 1 syndrome.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  Acute decompensated heart failure; Acute kidney injury; Cardiorenal cross talk; Cardiorenal syndrome; Cytokines; Inflammation; Oxidative stress; Tissue damage

Mesh:

Substances:

Year:  2018        PMID: 30205401      PMCID: PMC6477492          DOI: 10.1159/000492602

Source DB:  PubMed          Journal:  Cardiorenal Med        ISSN: 1664-5502            Impact factor:   2.041


  7 in total

1.  Lipopolysaccharide in systemic circulation induces activation of inflammatory response and oxidative stress in cardiorenal syndrome type 1.

Authors:  Grazia Maria Virzì; Andrea Breglia; Chiara Castellani; Ghada Ankawi; Chiara Bolin; Massimo de Cal; Vito Cianci; Annalisa Angelini; Giorgio Vescovo; Claudio Ronco
Journal:  J Nephrol       Date:  2019-04-20       Impact factor: 3.902

Review 2.  Beyond the Cardiorenal Syndrome: Pathophysiological Approaches and Biomarkers for Renal and Cardiac Crosstalk.

Authors:  Oana Nicoleta Buliga-Finis; Anca Ouatu; Minerva Codruta Badescu; Nicoleta Dima; Daniela Maria Tanase; Patricia Richter; Ciprian Rezus
Journal:  Diagnostics (Basel)       Date:  2022-03-22

Review 3.  Biomarkers in Stress Related Diseases/Disorders: Diagnostic, Prognostic, and Therapeutic Values.

Authors:  Kuldeep Dhama; Shyma K Latheef; Maryam Dadar; Hari Abdul Samad; Ashok Munjal; Rekha Khandia; Kumaragurubaran Karthik; Ruchi Tiwari; Mohd Iqbal Yatoo; Prakash Bhatt; Sandip Chakraborty; Karam Pal Singh; Hafiz M N Iqbal; Wanpen Chaicumpa; Sunil Kumar Joshi
Journal:  Front Mol Biosci       Date:  2019-10-18

Review 4.  OX-HDL: A Starring Role in Cardiorenal Syndrome and the Effects of Heme Oxygenase-1 Intervention.

Authors:  Stephen J Peterson; Abu Choudhary; Amardeep K Kalsi; Shuyang Zhao; Ragin Alex; Nader G Abraham
Journal:  Diagnostics (Basel)       Date:  2020-11-20

5.  Grb2 Induces Cardiorenal Syndrome Type 3: Roles of IL-6, Cardiomyocyte Bioenergetics, and Akt/mTOR Pathway.

Authors:  Jin Wang; Xuefeng Sun; Xu Wang; Shaoyuan Cui; Ran Liu; Jiaona Liu; Bo Fu; Ming Gong; Conghui Wang; Yushen Shi; Qianqian Chen; Guangyan Cai; Xiangmei Chen
Journal:  Front Cell Dev Biol       Date:  2021-03-22

Review 6.  Insights of Worsening Renal Function in Type 1 Cardiorenal Syndrome: From the Pathogenesis, Biomarkers to Treatment.

Authors:  Kang Fu; Yue Hu; Hui Zhang; Chen Wang; Zongwei Lin; Huixia Lu; Xiaoping Ji
Journal:  Front Cardiovasc Med       Date:  2021-12-14

Review 7.  Macrophage migration inhibitory factor in acute kidneyinjury.

Authors:  Yiwei Du; Hao Hao; Heng Ma; Hongbao Liu
Journal:  Front Physiol       Date:  2022-09-02       Impact factor: 4.755

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.